Testicular non-seminomatous germ cell tumor

Clinical trials for Testicular non-seminomatous germ cell tumor explained in plain language.

Never miss a new study

Get alerted when new Testicular non-seminomatous germ cell tumor trials appear

Sign up with your email to follow new studies for Testicular non-seminomatous germ cell tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Immunotherapy duo takes on rare tumors

Disease control Ongoing

This phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…

Matched conditions: TESTICULAR NON-SEMINOMATOUS GERM CELL TUMOR

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Testicular non-seminomatous germ cell tumor

Get alerted when new Testicular non-seminomatous germ cell tumor trials appear

Immunotherapy duo takes on rare tumors